Similar companies
Income Statement (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Revenue | 24M | 799.2% |
| Gross Profit | 16M | 90.9% |
| Cost of Revenue | 8.2M | 169.7% |
| Operating expense | 17M | 147% |
| Net Income | -450,000 | 103.6% |
| EBITDA | 170,000 | 97.5% |
Balance Sheet (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Total Assets | 395M | 1.1% |
| Total Liabilities | 43M | 15.9% |
| Total Equity | 353M | 1.1% |
| Shares Outstanding | 47M | 2.3% |
Cash Flow (USD)
| Q1 '25 | QoQ | |
|---|---|---|
| Cash from operations | 1.7M | 5% |
| Cash from financing | -3M | 26.8% |
EPS
Financial Highlights for BioLife Solutions in Q1 '25
BioLife Solutions reported a revenue of 24M, which is a 799.2% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 16M, marking a 90.9% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 8.2M, a 169.7% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 17M, showing a 147% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -450,000, showing a -103.6% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 170,000, showing a -97.5% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
BioLife Solutions faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
